Performance of Menarini CGM during normal daily life activities

Performance of the GlucoMen® Day (WaveForm Cascade) Continuous Glucose Monitor (CGM) in daily practice

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON25228

Enrollment

Registered

2020-11-03

Start date

2020-11-03

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

Wearing a CGM to assess reliability and accuracy of glucose measurements. Specifically: comparison of the device with capillary measurements.

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with type 1 diabetes mellitus, using insulin either by MDI or CSII. Ability to provide oral and written informed consent

Exclusion criteria

Exclusion criteria: Main exclusion criteria are the inability to understand the Dutch language and the presence of a severe or unstable medical condition.

Design outcomes

Primary

Measure	Time frame
The performance of the M-CGM compared to Nova capillary test strip during the 14-day study period.	—

Secondary

Measure	Time frame
The performance of the M-CGM compared to concomitantly used own FGM or rt-CGM device	—

Contacts

Public ContactPeter van Dijk

UMCG

p.r.van.dijk@umcg.nl0503618679

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)